RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Guelph General Hospital in Canada will be the first in the country to add Sectra's digital pathology ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

Foresee Pharmaceuticals (TPEx: 6576) ('Foresee') announced today that it will actively participate in and Toby Maher, M.D., will deliver a keynote presentation titled 'SyMMPonia: A Phase 2 Study of ...

Mass General Brigham researchers created an AI tool that uses a simple face photograph to predict how well a patient may fare ...

AI in India addresses radiologist shortage by halving reporting times, increasing accuracy, and aiding in rural healthcare.

For Charles Awoniyi, he stands at the forefront of healthcare transformation, leveraging his expertise in artificial ...

The first AI-powered companion diagnostic for non-small cell lung cancer has received FDA Breakthrough Device Designation. Developed by Roche, Ventana TROP2 RxDx Device combines IHC with a digital ...

it provides relative functional information related to pulmonary ventilation and circulation. Given the advantages of DCR, it may be a useful tool for identifying disease characteristics where ...

MHE: What are the latest insights into the underlying pathophysiology of pulmonary arterial hypertension (PAH ... Enhanced imaging technology in echocardiography has come to provide clearer images for ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...